Ramya (@ramyapharmd) 's Twitter Profile
Ramya

@ramyapharmd

CVICU Clinical Pharmacist • Baylor St. Luke’s- Texas Medical Center 💊 #TwitteRx #ViewsMyOwn

ID: 1221420404708913153

calendar_today26-01-2020 13:11:41

522 Tweet

540 Followers

284 Following

ACCP Cardiology PRN (@accpcardprn) 's Twitter Profile Photo

#WNW A recent NEJM trial presented at European Society of Cardiology 2023 meeting, the NOAH-AFNET-6 trial, found that DOACs🚫prevent clinical events in patients with device detected high atrial rate episodes, but did ⬆️ bleeding events. Check out the summary below! bit.ly/44J7WtZ

#WNW A recent <a href="/NEJM/">NEJM</a> trial presented at <a href="/escardio/">European Society of Cardiology</a> 2023 meeting, the NOAH-AFNET-6 trial, found that DOACs🚫prevent clinical events in patients with device detected high atrial rate episodes, but did ⬆️ bleeding events. Check out the summary below! bit.ly/44J7WtZ
American College of Cardiology (@accintouch) 's Twitter Profile Photo

The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis & Management of #AFib provides updated guidance for clinicians and emphasizes a rhythm control strategy & the need for lifestyle & risk factor modification in addition to medical treatment. Read the full guideline:

The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis &amp; Management of #AFib provides updated guidance for clinicians and emphasizes a rhythm control strategy &amp; the need for lifestyle &amp; risk factor modification in addition to medical treatment. Read the full guideline:
Circulation (@circaha) 's Twitter Profile Photo

2023 American Heart Association Focused Update on Adult Advanced Cardiovascular Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care #AHAJournals ahajrnls.org/483JsxW

American College of Cardiology (@accintouch) 's Twitter Profile Photo

🔑 Colchicine 0.5 mg daily is FDA-approved for secondary prevention in patients w/ coronary artery disease. Read key points to remember from a state-of-the-art review on the long-term safety of low-dose colchicine for atherosclerosis: bit.ly/4aUjBJN #cvPrev

Ian B. Hollis (@ianbhollis) 's Twitter Profile Photo

A compilation of ~15 years of data on the battle against HRAEs across several types of durable CF-LVADs, designed to provide insight into contemporary management...excellent multidisciplinary work by an impressive list of authors!

Cait E. Kulig 🇺🇦 (@cait_centra) 's Twitter Profile Photo

ACCP Cardiology PRN so this tPA shortage.....anyone using anything else for mechanical thrombectomy/EKOS/etc that they are willing to share? plz and thank uuuuuu

Ramya (@ramyapharmd) 's Twitter Profile Photo

Come meet with our current PGY1 and PGY2 residents on Dec 4th to learn more about our residency/fellowship programs at our virtual open house!

Come meet with our current PGY1 and PGY2 residents on Dec 4th to learn more about our residency/fellowship programs at our virtual open house!
ACCP Cardiology PRN (@accpcardprn) 's Twitter Profile Photo

Please join us on Tuesday, July 29 at 2pm CST for our July Journal Club! PGY2 Residents, Dr. Kayla Wesley and Dr. Emily Quach, will present the OCEANIC AF trial and AZALEA TIMI 71 trials! Zoom link on PRN list serve. Come learn about the latest in AF anticoagulation 🩸

Mark Cuban Cost Plus Drug Company (@costplusdrugs) 's Twitter Profile Photo

📢 Generic Entresto is now available at Cost Plus Drugs ❗️ Sacubitril/Valsartan is now on costplusdrugs.com. A big step forward for those managing chronic heart failure. Available in: 💊 24mg/26mg 30 tablets - $33.75 - costplusdrugs.com/medications/sa… 💊 49mg/51mg 30 tablets -

📢 Generic Entresto is now available at Cost Plus Drugs ❗️

Sacubitril/Valsartan is now on costplusdrugs.com. A big step forward for those managing chronic heart failure.

Available in:
💊 24mg/26mg 30 tablets - $33.75 - costplusdrugs.com/medications/sa…
💊 49mg/51mg 30 tablets -
ACCP Cardiology PRN (@accpcardprn) 's Twitter Profile Photo

🚨Please join us TODAY at 2pm CST for our July Journal Club!🚨 PGY2 Residents, Dr. Kayla Wesley and Dr. Emily Quach, will present the OCEANIC AF trial and AZALEA TIMI 71 trials! Zoom link on PRN list serve. Come learn about the latest in AF anticoagulation 🩸